Cat missing for 20 years reunited with owner for last two days of its life

Ulta Beauty, Inc. Q4 adjusted earnings Beat Estimates

Ulta Beauty, Inc. (ULTA) revealed a profit for fourth quarter that decreased from the same period last year.

The company’s earnings totaled $171.49 million, or $3.03 per share. This compares with $222.72 million, or $3.89 per share, in last year’s fourth quarter.

Excluding items, Ulta Beauty, Inc. reported adjusted earnings of $193.36 million or $3.41 per share for the period.

Analysts had expected the company to earn $2.35 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.

The company’s revenue for the quarter fell 4.8% to $2.20 billion from $2.31 billion last year.

Ulta Beauty, Inc. earnings at a glance:

-Earnings (Q4): $193.36 Mln. vs. $219.49 Mln. last year.
-EPS (Q4): $3.41 vs. $3.83 last year.
-Analysts Estimate: $2.35
-Revenue (Q4): $2.20 Bln vs. $2.31 Bln last year.

How animal hides are made into parchment at the last workshop of its kind in the US

• Pergamena is the last company in the US that uses animal skins to make parchment.
• The craft dates back to 2500 BC and was most popular during the Middle Ages, before paper was industrialized.
• CEO Jesse Meyer taught himself the craft as a way to revitalize his family’s nearly 500-year-old tannery business.
• See more stories on Insider’s business page.

Novavax Confirms 96% Efficacy Against Original COVID-19 Strains In UK

Shares of Novavax, Inc. (NVAX) jumped over 20% in extended trading hours on Thursday after the biotechnology company confirmed high levels of efficacy against original and variant COVID-19 strains in United Kingdom and South Africa trials.

Novavax announced final efficacy of 96.4% against the original COVID-19 strain in a pivotal Phase 3 trial in the UK of NVX-CoV2373, the company’s vaccine candidate.

The company also announced the complete analysis of its Phase 2b trial taking place in South Africa, with efficacy of 55.4% among the HIV- negative trial participants in a region where the vast majority of strains are B1.351 escape variants.

Across both trials, NVX-CoV2373 demonstrated 100% protection against severe disease, including all hospitalization and death.

“We are very encouraged by the data showing that NVX-CoV2373 not only provided complete protection against the most severe forms of disease, but also dramatically reduced mild and moderate disease across both trials. Importantly, both studies confirmed efficacy against the variant strains,” said Stanley Erck, President and Chief Executive Officer, Novavax.

In the UK trial, the vaccine was found 96.4% effective against the original virus strain and 86.3% against the U.K variant. The primary efficacy endpoint demonstrated an overall vaccine efficacy of 89.7%.

NVAX closed Thursday’s trading at $187.63, up $15.13 or 8.77%, on the Nasdaq. The stock further gained $38.48 or 20.51% in the after-hours trade.

UTA Signs ‘Safety’ Actor Jay Reeves

EXCLUSIVE: UTA has signed actor Jay Reeves, who stars in the sports drama Safety based on the true on Disney+.

Directed by Reginald Hudlin, Safety is based on the true story of Ray McElrathbey, a football player at Clemson University who took in his brother and raised him on campus after family life at home became too unstable.

In addition to Safety, Reeves appeared in David Ayer’s The Tax Collector opposite Shia LeBeouf. On the television side, he appeared in a multi-episode arc as Shawn Scott in the first season of the CW series, All American.

Reeves will continue to be repped by Lena Roklin and Jomer Calma of Luber Roklin Entertainment.

Read More About:

China Sets Growth Target For 2021

China’s government has set growth target for 2021, at the annual parliamentary meeting on Friday, as it recovers from the coronavirus pandemic.

At the opening of the National People’s Congress, Premier Li Keqiang announced that the government targets to achieve above 6 percent economic growth this year.

In 2020, the government avoided setting an annual growth target due to uncertainty caused by the coronavirus pandemic.

“A target of over 6% will enable all of us to devote full energy to promoting reform, innovation, and high-quality development,” Li said.

The economy had expanded 2.3 percent last year, making China the only major economy to avoid a contraction amid the Covid-19 pandemic. However, this was the weakest growth since 1970s.

The very low GDP growth target for 2021 seems like there was no target at all because the consensus was 8 percent and ING’s forecast of 7 percent, Iris Pang, an economist at ING said.

The fiscal deficit is expected to be about 3.2 percent of GDP compared to 3.6 percent in 2020.

Li said there are impediments to consumer spending. The latest government work report has focused on technology development and investment in research.

The surveyed jobless rate in urban areas is projected to reach 5.5 percent this year. The government plans to create more than 11 million urban jobs compared to over 9 million employment in 2020.

The government forecast consumer prices to rise around 3 percent in 2021.